ArticleBioinformatics (Oxford, England)2025
AOP-helpFinder 3.0: from text mining to network visualization of key event relationships, and knowledge integration from multiple sources.
Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Micro- and nanoplastics-induced neurotoxicity: a CNS-centered, evidence-graded adverse outcome pathway framework based on systematic weight-of-evidence assessment.Archives of toxicology · 2026Review
- Towards Bayesian-based quantitative adverse outcome pathways using in vitro data from open literature and continuous variables: a case example for liver fibrosis.Toxicological sciences : an official journal of the Society of Toxicology · 2026Article
- Inhibitory binding to plastoquinone B site on D1 protein of photosystem II leading to decreased population growth rate via disruption of cellular energy metabolism.Frontiers in plant science · 2026Review
- New approach methodologies (NAMs) to support regulatory assessment of developmental immunotoxicity - a new PARC project.Frontiers in toxicology · 2026Review
- The FAIR AOP roadmap for 2025: Advancing findability, accessibility, interoperability, and re-usability of adverse outcome pathways.Computational toxicology (Amsterdam, Netherlands) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
motivationThe Adverse Outcome Pathways (AOP) framework advances alternative toxicology by prioritizing the mechanisms underlying toxic effects. It organizes existing knowledge in a structured way, tracing the progression from the initial perturbation of a molecular event, caused by various stressors, through key events across different biological levels, ultimately leading to adverse outcomes that affect human health and ecosystems. However, the increasing volume of toxicological data presents a significant challenge for integrating all available knowledge effectively.
resultsText mining techniques, including natural language processing and graph-based approaches, provide powerful methods to analyze and integrate large, heterogeneous data sources. Within this framework, the AOP-helpFinder TM tool, accessible as a web server, was created to identify stressor-event and event-event relationships by automatically screening scientific literature in the PubMed database, facilitating the development of AOPs. The proposed new version introduces enhanced functionality by incorporating additional data sources, automatically annotating events from the literature with toxicological database information in a systems biology context. Users can now visualize results as interactive networks directly on the web server. With these advancements, AOP-helpFinder 3.0 offers a robust solution for integrative and predictive toxicology, as demonstrated in a case study exploring toxicological mechanisms associated with radon exposure. AVAILABILITY AND IMPLEMENTATION: AOP-helpFinder is available at https://aop-helpfinder-v3.u-paris-sciences.fr.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.